294 related articles for article (PubMed ID: 20833496)
1. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between ductal carcinoma in situ and mastopathy using dynamic contrast-enhanced magnetic resonance imaging and a model of contrast enhancement.
Nishiura M; Tamaki Y; Murase K
Eur J Radiol; 2011 Dec; 80(3):740-3. PubMed ID: 21030170
[TBL] [Abstract][Full Text] [Related]
3. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
[TBL] [Abstract][Full Text] [Related]
6. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
[TBL] [Abstract][Full Text] [Related]
7. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
[TBL] [Abstract][Full Text] [Related]
9. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
[TBL] [Abstract][Full Text] [Related]
10. Can color-coded parametric maps improve dynamic enhancement pattern analysis in MR mammography?
Baltzer PA; Dietzel M; Vag T; Beger S; Freiberg C; Herzog AB; Gajda M; Camara O; Kaiser WA
Rofo; 2010 Mar; 182(3):254-60. PubMed ID: 19862654
[TBL] [Abstract][Full Text] [Related]
11. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
12. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
13. Comment on ADC reductions in postcontrast breast tumors.
Ramadan S; Mulkern RV
J Magn Reson Imaging; 2010 Jan; 31(1):262; author reply 263-4. PubMed ID: 20027600
[No Abstract] [Full Text] [Related]
14. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Female Breast Imaging (MRFBI) - Evaluation of the Changes in Signal Intensity over Time Pre- and Post-administration of 0.2 mmol/kg Gd-DTPA.
Schedel H; Oellinger H; Kohlschein P; Siewert C; Hadijuana J; Blohmer JU; Kissner T; Felix R
Zentralbl Gynakol; 2002 Feb; 124(2):104-10. PubMed ID: 11935495
[TBL] [Abstract][Full Text] [Related]
16. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
[TBL] [Abstract][Full Text] [Related]
17. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
18. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
[TBL] [Abstract][Full Text] [Related]
19. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
20. Peripheral hyperintense pattern on T2-weighted magnetic resonance imaging (MRI) in breast carcinoma: correlation with early peripheral enhancement on dynamic MRI and histopathologic findings.
Kawashima H; Kobayashi-Yoshida M; Matsui O; Zen Y; Suzuki M; Inokuchi M
J Magn Reson Imaging; 2010 Nov; 32(5):1117-23. PubMed ID: 21031517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
